I-SARS-CoV-2, iKit yokuFumanisa i-Influenza A&B Antigen Combined Detection Kit-EU CE

I-COVID-19, iFlu A okanye iFlu B zineempawu ezifanayo, nto leyo eyenza kube nzima ukwahlula phakathi kwezo zifo zintathu zentsholongwane. Ukuxilongwa okwahlukileyo ukuze ufumane unyango olufanelekileyo kufuna uvavanyo oludibeneyo ukuze kuchongwe intsholongwane ethile eyosulelekileyo.

Iimfuno

Ukuxilongwa ngokuchanekileyo kokwahluka kubalulekile ukuze kukhokelwe unyango olufanelekileyo lwe-antiviral.

Nangona zineempawu ezifanayo, usulelo lwe-COVID-19, i-Flu A kunye ne-Flu B zifuna unyango olwahlukileyo lokulwa neentsholongwane. I-Influenza inokunyangwa ngezithinteli ze-neuraminidase kunye ne-COVID-19 enzima nge-remdesivir/sotrovimab.

Iziphumo ezilungileyo kwintsholongwane enye azithethi ukuba ukhululekile kwezinye. Usulelo oluhambisanayo lunyusa umngcipheko wesifo esibi, ukulaliswa esibhedlele, ukufa ngenxa yeziphumo ezihambelanayo.

Ukuxilongwa ngokuchanekileyo ngovavanyo lwe-multiplex kubalulekile ukuze kukhokelwe unyango olufanelekileyo lwee-antiviral, ingakumbi xa kukho izifo ezinokubakho ngexesha lexesha le-peak respiratory virus.

Izisombululo Zethu

Uvavanyo lweMacro kunye nolweMicroUkufunyanwa okuDibeneyo kwe-SARS-CoV-2, i-Influenza A&B Antigen, yahlula iFlu A, iFlu B kunye neCOVID-19 kunye nosulelo oluninzi olunokubakho ngexesha lesifo sokuphefumla;

Uvavanyo olukhawulezileyo lwezifo ezininzi zokuphefumla, kuquka i-SARS-CoV-2, i-Flu A, kunye ne-Flu B ngesampulu enye;

Idityaniswe ngokupheleleyo umcu wovavanyo onendawo enye yokufaka isicelo kunye nesampulu enye efunekayo ukwahlula phakathi kwe-Covid-19, i-Flu A kunye ne-Flu B;

Amanyathelo ama-4 kuphela okukhawulezisa iziphumo zithatha imizuzu eli-15 ukuya kwengama-20 kuphela, nto leyo evumela ukuba kwenziwe izigqibo zonyango ngokukhawuleza.

Iintlobo ezininzi zeesampulu: I-Nasopharyngeal, i-Oropharyngeal okanye i-Early Renal;

Ubushushu bokugcina: 4 -30°C;

Ishelufu Ubomi: Iinyanga ezingama-24.

Iimeko ezininzi ezifana nezibhedlele, iikliniki, amaziko empilo oluntu, iikhemesti, njl.

	I-SARS-CoV-2	Umkhuhlane A	UmkhuhlaneB
Uvelwano	94.36%	94.92%	93.79%
Ukuchaneka	99.81%	99.81%	100.00%
Ukuchaneka	98.31%	98.59%	98.73%